Ansell's revenue in the first quarter of China reached 29.4 billion Japanese yen, a year-on-year increase of 57.8%.

On August 4th, according to the financial report released by AstraZeneca Pharmaceuticals Group, the operating income for the first quarter of the 2025 fiscal year was 505.8 billion yen, an increase of 6.9% year-on-year, and the core operating profit was 142.3 billion yen, an increase of 61.1% year-on-year.